BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4908595)

  • 1. Clinical trial of new attenuated mumps virus vaccine (Jeryl Lynn strain): preliminary report.
    Pagano JS; Levine RH; Sugg WC; Finger JA
    Prog Immunobiol Stand; 1967; 3():196-202. PubMed ID: 4908595
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak.
    Rubin SA; Qi L; Audet SA; Sullivan B; Carbone KM; Bellini WJ; Rota PA; Sirota L; Beeler J
    J Infect Dis; 2008 Aug; 198(4):508-15. PubMed ID: 18558869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infants' responses to live, attenuated, B level, Jeryl Lynn mumps vaccine.
    Wilkins J; Williams FF; Wehrle PF
    Am J Dis Child; 1972 Jul; 124(1):66-7. PubMed ID: 5033752
    [No Abstract]   [Full Text] [Related]  

  • 4. Persistence of immunity four years following Jeryl Lynn strain live mumps virus vaccine.
    Weibel RE; Buynak EB; Stokes J; Hilleman MR
    Pediatrics; 1970 May; 45(5):821-6. PubMed ID: 5444402
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative efficacy of Rubini, Jeryl-Lynn and Urabe mumps vaccine in an Asian population.
    Ong G; Goh KT; Ma S; Chew SK
    J Infect; 2005 Nov; 51(4):294-8. PubMed ID: 16291282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination of school children with live mumps virus vaccine.
    Furesz J; Nagler FP
    Can Med Assoc J; 1970 May; 102(11):1153-5. PubMed ID: 5420994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and serological studies in Mexico with live attenuated mumps virus vaccine. (Jerry Lynn strain).
    Ramos Alvarez M; Bessudo L
    Rev Invest Salud Publica; 1972; 32(2):104-8. PubMed ID: 4584449
    [No Abstract]   [Full Text] [Related]  

  • 8. Jeryl Lynn Strain Live Attenuated Mumps Virus vaccine in a private pediatric practice.
    Nickey LN; Huchton P; McGee WG
    South Med J; 1970 Mar; 63(3):306-8. PubMed ID: 4905918
    [No Abstract]   [Full Text] [Related]  

  • 9. Jeryl Lynn strain live mumps virus vaccine. Durable immunity for three years following vaccination.
    Weibel RE; Buynak EB; Whitman JE; Leagus MB; Stokes J; Hilleman MR
    JAMA; 1969 Mar; 207(9):1667-70. PubMed ID: 5818350
    [No Abstract]   [Full Text] [Related]  

  • 10. Rubini, a new live attenuated mumps vaccine virus strain for human diploid cells.
    Glück R; Hoskins JM; Wegmann A; Just M; Germanier R
    Dev Biol Stand; 1986; 65():29-35. PubMed ID: 3556774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and biological properties of a new live attenuated mumps vaccine.
    Saika S; Kidokoro M; Kubonoya H; Ito K; Ohkawa T; Aoki A; Nagata N; Suzuki K
    Comp Immunol Microbiol Infect Dis; 2006; 29(2-3):89-99. PubMed ID: 16647119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on live mumps virus vaccine. IV. Clinical and serological follow-up 2 year and 3 years after vaccination.
    Yamanishi K; Takahashi M; Kurimura T; Ueda S; Suzuki N
    Biken J; 1971 Sep; 14(3):259-65. PubMed ID: 5156905
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on live attenuated mumps vaccine. II. Follow-up study on the efficacy of Biken Vaccine.
    Isomura S; Ozaki T; Morishima T; Nagayoshi S; An S
    Biken J; 1976 Sep; 19(3):115-8. PubMed ID: 1016214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo growth alter the population dynamic and properties of a Jeryl Lynn mumps vaccine.
    Connaughton SM; Wheeler JX; Vitková E; Minor P; Schepelmann S
    Vaccine; 2015 Aug; 33(36):4586-93. PubMed ID: 26187256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mumps: efficacy of booster immunization].
    Gassner M; Hess U; Berger R
    Schweiz Med Wochenschr; 1995 Dec; 125(51-52):2506-10. PubMed ID: 8571103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mumps virus vaccine.
    Smith MH
    Pediatrics; 1969 May; 43(5):907-9. PubMed ID: 5786553
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical evaluation of a new measles-mumps-rubella combined live virus vaccine in the Dominican Republic.
    Ehrenkranz NJ; Ventura AK; Medler EM; Jackson JE; Kenny MT
    Bull World Health Organ; 1975; 52(1):81-5. PubMed ID: 764997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phylogenetic analysis of clinical mumps virus isolates from vaccinated and non-vaccinated patients with mumps during an outbreak, Switzerland 1998-2000.
    Utz S; Richard JL; Capaul S; Matter HC; Hrisoho MG; Mühlemann K
    J Med Virol; 2004 May; 73(1):91-6. PubMed ID: 15042654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experiences with Jeryl Lynn strain live attenuated mumps virus vaccine in a pediatric outpatient clinic.
    Young ML; Dickstein B; Weibel RE; Stokes J; Buynak EB; Hilleman MR
    Pediatrics; 1967 Nov; 40(5):798-803. PubMed ID: 6075651
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anti-mumps vaccination with live attenuated vaccine in a children's community].
    Drouhet V; Celers J; Minvielle A; Lévy-Thierry S
    Ann Pediatr (Paris); 1971 Apr; 18(4):277-85. PubMed ID: 5574000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.